文献速递冠心病血脂与心血管预防

CYP7A1基因变异与心肌梗死及症状性胆结石风险

Genetic variants in CYP7A1 and risk of myocardial infarction and symptomatic gallstone disease.
PubMed 文献 · Eur Heart J · 2018-01-01

在普通人群中检测CYP7A1基因罕见和常见变异与血脂及疾病关联,发现升高LDL胆固醇的变异经加权等位基因评分与心肌梗死和症状性胆结石风险增加相关。

要点

  • CYP7A1罕见变异等位基因计数最高者LDL胆固醇升高12%(0.4 mmol/L)。
  • 常见变异加权评分>0.04 vs ≤0者LDL胆固醇升高至多2.4%(0.08 mmol/L)。
  • 该评分与心肌梗死(HR 1.25)和症状性胆结石(HR 1.39)风险增加相关。

核心结论

  • CYP7A1基因变异与LDL胆固醇升高相关,并与心肌梗死和症状性胆结石风险增加相关。

研究设计与样本

  • 在100 149名普通人群个体中检测8个罕见非同义突变和2个常见变异(rs2081687、rs3808607)与血脂的关联。
  • 进一步检验与LDL胆固醇升高相关的加权等位基因评分与心肌梗死及症状性胆结石风险的关联,平均随访7年(0-23年)。

主要发现

  • 随访期间2326人发生心肌梗死,2007人发生症状性胆结石。
  • 罕见突变:等位基因计数最高 vs 最低者LDL胆固醇升高12%(0.4 mmol/L),趋势P=3×10-4。
  • 常见变异加权评分>0.04 vs ≤0者LDL胆固醇阶梯式升高至多2.4%(0.08 mmol/L)。
  • 该评分对应多因素校正后心肌梗死HR 1.25(95%CI 1.10-1.41),症状性胆结石HR 1.39(95%CI 1.22-1.59),趋势P分别为5×10-4和2×10-7。
  • 包含大型联盟公开数据的荟萃分析结果类似。

临床怎么用

  • CYP7A1变异所致LDL胆固醇升高可能同时增加心肌梗死和症状性胆结石风险,提示降LDL治疗可能对两者均有获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Myocardial infarction (MI) and gallstone disease (GSD) are intrinsically linked via cholesterol metabolism. We tested the hypothesis that genetic variants in the gene encoding cholesterol 7 alpha-hydroxylase (CYP7A1), the rate-limiting enzyme in the conversion of cholesterol to bile acids in the liver, are associated with risk of MI and GSD in the general population. METHODS AND RESULTS: We performed tests of association between lipid levels and eight rare non-synonymous mutations and two common variants, rs2081687 and rs3808607, in CYP7A1 in 100 149 individuals from the general population. We further tested whether weighted allele scores for rs2081687 and rs3808607, which were associated with increased plasma levels of low-density lipoprotein (LDL) cholesterol, were associated with an increased risk of both MI and symptomatic GSD. During a mean follow-up of 7 years (0-23 years), MI developed in 2326 individuals and GSD in 2007. For rare mutations, CYP7A1 allele count was associated with an increase in LDL cholesterol of 12% (0.4 mmol/L) for individuals with the highest vs. the lowest allele count (P for trend = 3 × 10-4). For common variants, CYP7A1 weighted allele scores in individuals with a score >0.04 vs. ≤0 were associated with stepwise increases in LDL cholesterol of up to 2.4% (0.08 mmol/L), and with corresponding multifactorially adjusted hazard ratios of 1.25 [95% confidence interval (CI) 1.10-1.41] for MI and 1.39 (95% CI 1.22-1.59) for GSD (P for trend = 5 × 10-4 and 2 × 10-7, respectively). Results were similar in meta-analyses including publicly available data from large consortia. CONCLUSION: Genetic variants in CYP7A1 which are associated with increased levels of LDL cholesterol, are associated with an increased risk of both MI and GSD.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Qayyum F, Lauridsen BK, Frikke-Schmidt R, et al. Genetic variants in CYP7A1 and risk of myocardial infarction and symptomatic gallstone disease. Eur Heart J. 2018. PMID: 29529257. doi:10.1093/eurheartj/ehy068

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。